Want to see HK:1833 full AI Analyst Report?
1833 Stock Chart & Stats
HK$6.64
HK$0.15(2.03%)
At close: 4:00 PM EDT
HK$6.64
HK$0.15(2.03%)
Day’s Range― - ―
52-Week RangeHK$5.29 - HK$18.79
Previous CloseN/A
Volume6.53M
Average Volume (3M)7.16M
Market Cap
HK$11.94B
Enterprise ValueHK$6.58B
Total Cash (Recent Filing)HK$7.20B
Total Debt (Recent Filing)HK$29.05M
Price to Earnings (P/E)21.4
Beta1.09
Next Earnings
Mar 16, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield160.6%
Share Statistics
EPS (TTM)0.22
Shares Outstanding2,161,443,600
10 Day Avg. Volume6,720,059
30 Day Avg. Volume7,159,207
Financial Highlights & Ratios
PEG Ratio0.50
Price to Book (P/B)2.63
Price to Sales (P/S)4.77
P/FCF Ratio66.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$12.26Price Target Upside84.59% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.14
Revenue Forecast (FY)HK$4.97B
Bulls Say, Bears Say
Bulls Say
Profitability TurnaroundMoving from sizable losses through 2023 to positive net income in 2024 and a stronger 2025 result indicates a meaningful operating turnaround. Positive EBIT and higher EBITDA can support reinvestment and make the platform’s earnings base more durable.
Very Low LeverageExtremely low debt relative to equity limits interest and refinancing pressure, preserving financial flexibility during market or operating setbacks. The conservative balance sheet also gives the company greater capacity to fund healthcare-platform investment without relying heavily on additional borrowing.
Improving Free Cash FlowThe shift to positive operating and free cash flow, followed by further strengthening in 2025, improves the quality of the profitability recovery. Free cash flow close to net income also supports internally funded investment and reduces dependence on external capital.
Bears Say
Volatile Revenue TrajectoryThe sharp earlier revenue contraction and only modest growth in 2024 show that demand and expansion have not followed a consistently upward path. This volatility makes future scale benefits less predictable and can limit confidence in the durability of the earnings recovery.
Uneven Cash ConversionAlthough cash flow improved materially, the history of deep outflows and relatively low coverage indicates that reported earnings may not convert into cash consistently. Continued sensitivity to working-capital or non-cash swings could constrain the reliability of funding for operations and growth.
Equity Base VolatilityA large change in reported equity introduces uncertainty into the company’s capitalization and return metrics even though debt remains very low. If such movements recur, they could complicate assessment of underlying financial strength and reduce predictability in balance-sheet planning.
Ping An Healthcare and Technology Company News
1833 FAQ
What was Ping An Healthcare and Technology Company Limited’s price range in the past 12 months?
Ping An Healthcare and Technology Company Limited lowest stock price was HK$5.29 and its highest was HK$18.79 in the past 12 months.
What is Ping An Healthcare and Technology Company Limited’s market cap?
Ping An Healthcare and Technology Company Limited’s market cap is HK$11.94B.
When is Ping An Healthcare and Technology Company Limited’s upcoming earnings report date?
Ping An Healthcare and Technology Company Limited’s upcoming earnings report date is Mar 16, 2027 which is in 143 days.
How were Ping An Healthcare and Technology Company Limited’s earnings last quarter?
Ping An Healthcare and Technology Company Limited released its earnings results on Aug 19, 2026. The company reported HK$0.117 earnings per share for the quarter.
Is Ping An Healthcare and Technology Company Limited overvalued?
According to Wall Street analysts Ping An Healthcare and Technology Company Limited’s price is currently Undervalued.
Does Ping An Healthcare and Technology Company Limited pay dividends?
Ping An Healthcare and Technology Company Limited pays a Notavailable dividend of HK$9.7 which represents an annual dividend yield of 160.6%. See more information on Ping An Healthcare and Technology Company Limited dividends here
What is Ping An Healthcare and Technology Company Limited’s EPS estimate?
Ping An Healthcare and Technology Company Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ping An Healthcare and Technology Company Limited have?
Ping An Healthcare and Technology Company Limited has 2,161,443,600 shares outstanding.
What happened to Ping An Healthcare and Technology Company Limited’s price movement after its last earnings report?
Ping An Healthcare and Technology Company Limited reported an EPS of HK$0.117 in its last earnings report. Following the earnings report the stock price went down -4.055%.
Which hedge fund is a major shareholder of Ping An Healthcare and Technology Company Limited?
Currently, no hedge funds are holding shares in HK:1833
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Ping An Healthcare and Technology Company Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$12.26 (84.59% Upside)
HK$12.26 (84.59% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-63.03%
12-Months-Change
Fundamentals
Return on Equity
4.62%
Trailing 12-Months
Asset Growth
6.62%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Ping An Healthcare and Technology Company Limited
Ping An Healthcare and Technology Company Limited (PAHT), through its subsidiaries, operates a comprehensive online platform that delivers healthcare services across the People's Republic of China. Its core offerings encompass virtual medical consultations, facilitated hospital referrals and appointment scheduling, inpatient care coordination, and expert second opinions. PAHT also provides standardized consumer healthcare packages, integrating services from a network of medical institutions. Beyond services, the company offers a broad array of products, including pharmaceuticals, health supplements, medical devices, wellness items such as fitness equipment and personal care products, and other miscellaneous goods. Furthermore, PAHT engages users with health management and wellness interaction services, featuring various programs, interactive tools, activities, and personalized content. Its additional operations include medicine marketing, technology services, application development and maintenance, direct hospital and clinic services, and the management of an insurance agency. Established in 2014, Ping An Healthcare and Technology Company Limited maintains its headquarters in Shanghai, China.
1833 Company Deck
1833 Earnings Call
Q2 2026
0:00 / 0:00
1833 Stock 12 Month Forecast
Average Price Target
HK$12.26
▲(84.59% Upside)
Technical Analysis
Dingdang Health Technology Group Ltd.
―
Perfect Medical Health Management Limited
―
Yidu Tech, Inc.
―
Medlive Technology Co., Ltd.
―
Xunfei Healthcare Technology Co., Ltd.
―